Article

Innovation Institutions and COVID-19

2021-04-15

Abstract excerpt

The COVID-19 crisis has starkly illustrated both the strengths and limitations of U.S. biomedical innovation institutions as deployed to fight a pandemic. These innovation institutions include not just intellectual property law, but also other legal systems that structure incentives for production and allocation of knowledge goods, including regulation by health agencies like the Food and Drug Administration, prog...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: adae113c-26ea-5dbb-856c-bcbc6611163f
DOI: 10.2139/ssrn.3826687

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Innovation Institutions and COVID-19DOI 10.2139/ssrn.3826687Read

Innovation Institutions and COVID-19, Part IISemantic proximity Read

The Intellectual Property of COVID-19Semantic proximity Read

Technological Exaptation to Support Innovation for COVID-19 Pandemic CrisisSemantic proximity Read

Innovation for challenges of public health and sustainable growthSemantic proximity Read

<strong>COVID19 PCR Testing and the Unprecedented Institutional Response in a Low-Resource Setting</strong>Semantic proximity Read

Analysis of recurrent research pathways for assessing and improving effectiveness in life sciences laboratoriesSemantic proximity Read

Innovation Incentives in the Pharmaceutical Sector: Re-thinking Competition and Public Policy?Semantic proximity Read

Biomedical and Healthtech Innovation: The Dilemma Between Purpose, Current Stakeholder Economics, and “Patient” Benefits / Desires — What Might the Future of Health Look Like?Semantic proximity Read

Designing and Resourcing European Medical Affairs Under the EU HTA Regulation: A Market Complexity Index for Hub-and-Spoke StructuresSemantic proximity Read

Promoting Vaccine InnovationSemantic proximity Read

Exploring Unique Device Identifier Implementation and Use for Real-World Evidence: A Mixed-Methods Study with NESTcc Health System Network CollaboratorsSemantic proximity Read

Strategic Use of Patent Opposition Safeguard to Improve Equitable Access to Innovative Health Technologies: A Case Study of CAR T-Cell Therapy KymriahSemantic proximity Read